08/31/2026
Colleagues from our Clinical Development and Medical Affairs teams recently attended the , focused on tuberous sclerosis complex (TSC), a rare genetic condition that causes noncancerous tumors to grow in the brain and other organs, often leading to seizures.
Attending the conference gave our team the chance to connect with people living with TSC and hear them describe the daily realities of living with the condition. Their challenges deserve wider recognition, and their perspectives should keep shaping education, care, research and future scientific advances. That work depends on the whole TSC and scientific community moving together.
Improving the lives of people affected by seizures is at the center of our mission, and we remain committed to listening, learning and identifying meaningful ways to support the communities connected to our work.